Endologix Buys TriVascular For $211m To Create Major AAA Player
This article was originally published in Clinica
Executive Summary
Endologix says it will have the broadest product portfolio for endovascular treatment of abdominal aortic aneurysms following the $211m acquisition of TriVascular announced on Oct. 26.